Recent advancements in the treatment of breast cancer have brought about significant improvements in patient care. These include the use of smaller operations, personalized treatment plans based on precision oncology, and the development of new targeted therapies for aggressive types of breast cancer such as triple-negative breast cancer. These advancements have led to better outcomes for patients by allowing for more effective and tailored treatment approaches.
Empowering Black Women: Latest Innovations in Breast Cancer Treatment
by Blackdoctor
The Latest In Breast Cancer

New Breast Cancer Research Offers Hope for Black Women
ASCO Data Shows New Therapy Delays Breast Cancer Progression and May Improve Quality of Life for Women with Hormone Receptor-Positive Disease Black women diagnosed with estrogen receptor-positive (ER-positive) breast cancer—a subtype that makes up the majority of breast cancer cases—face read more about New Breast Cancer Research Offers Hope for Black Women

Why This Black Woman’s ASCO Win Is a Game-Changer for Breast Cancer Advocacy
Karen Eubanks Jackson made history by becoming the first Black woman to receive the prestigious 2025 ASCO Patient Advocacy Award, an honor granted by the American Society of Clinical Oncology. But her story, one of resilience, vision, and unstoppable advocacy, read more about Why This Black Woman’s ASCO Win Is a Game-Changer for Breast Cancer Advocacy

How Digital Tools Are Redefining Breast Cancer Access
ASCO Exclusive: Josette Gbemudu Talks TNBC, Trust, and Technology in Women’s Health At the crossroads of innovation and equity, Josette Gbemudu is helping rewrite the narrative for women navigating one of the most daunting health challenges of their lives: breast read more about How Digital Tools Are Redefining Breast Cancer Access

Not Enough Black Women Live Near Clinical Trials for Breast Cancer
New research presented at the 2025 American Society for Clinical Oncology's (ASCO) annual meeting has shed light on the availability of clinical trials for triple-negative breast cancer (TNBC) across the United States, specifically focusing on whether these trials are located read more about Not Enough Black Women Live Near Clinical Trials for Breast Cancer

Triple-Negative Breast Cancer Clinical Trials for Black Women: How to Find Them
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer that tests negative for the three molecular components of breast cancer cells: estrogen receptors, progesterone receptors, and human epidermal growth factor protein (HER2). TNBC is more common in women read more about Triple-Negative Breast Cancer Clinical Trials for Black Women: How to Find Them

How Black Clinical Trial Participation Can End Health Care Inequalities
New medical treatments often come with great promise, but sometimes that promise doesn’t fully extend to Black Americans. “Populations of humans sometimes respond differently to different drugs," said Dr. Pierre Theodore, Executive Director Health Equity at Genentech Roche, in a read more about How Black Clinical Trial Participation Can End Health Care Inequalities